Back
ESC2025 Premium Access

Accurate and efficient cardio-oncology outpatient clinic summarization with open-source large language models for non-english text

Session: Risk scores in cardio-oncology
Topic: Research and New Technology
Speaker: Doctor J. Heemelaar (Leiden, NL)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Julius Heemelaar

Leiden University Medical Center, Leiden (Netherlands (The))
0 follower

6 more presentations in this session

Assessment of ESC risk stratification for cancer therapy-related cardiovascular toxicity in a real-world urban population

Speaker: Doctor J. Arnold (Chicago, US)

Access
Abstract
Slides
Like
Thumbnail

Systemic H-FABP, hs-cTnT, hs-CRP and Monocyte-to-Lymphocyte ratio were significantly reduced by sacubitril/valsartan in doxorubicin-treated preclinical models through NLRP3-mTOR-AKT pathways

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Hepcidin and cardiovascular events in patients with chronic kidney disease undergoing dialysis: a post-hoc analysis of the ASCEND-D trial

Speaker: Doctor Y. Fujimoto (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

The new mechanism of apatinib in treating gastric cancer-related hypertension: dynamin-related protein 1-mediated pathological mitochondrial fission in endothelial cells

Speaker: Doctor F. Si (Lanzhou, CN)

Access
Abstract
Slides
Like
Thumbnail

The diagnostic and prognostic value of high-sensitivity troponin T for cardiovascular outcomes in patients receiving immune checkpoint inhibitor therapy.

Speaker: Associate Professor C. Ayoub (Phoenix, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Risk scores in cardio-oncology

Speakers: Doctor J. Heemelaar, Doctor J. Arnold, Doctor N. Maurea, Doctor Y. Fujimoto, Doctor F. Si...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources